Increased serum concentration of immune cell derived microparticles in polymyositis/dermatomyositis

Zsuzsanna Baka1, Ladislav Senolt, Jiri Vencovsky

  • 1Department of Genetics, Semmelweis University, Budapest, Hungary.

Immunology Letters
|January 2, 2010
PubMed

Insights

Immune cell-derived microparticles are elevated in polymyositis/dermatomyositis patients, correlating with disease severity and specific antibodies. These microparticles may play a role in the inflammatory process of this autoimmune condition.

Area of Science:

  • Immunology
  • Cell Biology
  • Autoimmune Diseases

Background:

  • Microparticles are key mediators of intercellular communication, influencing cell signaling, activation, and apoptosis.
  • Their role is increasingly implicated in autoimmune conditions like rheumatoid arthritis and systemic sclerosis.
  • Polymyositis/dermatomyositis are rare autoimmune diseases characterized by muscle weakness and distinct skin manifestations.

Purpose of the Study:

  • To investigate the role and levels of monocyte and lymphocyte-derived microparticles in polymyositis/dermatomyositis.
  • To explore the correlation between microparticle levels and clinical parameters, including muscle strength and specific autoantibodies.
  • To examine the structural characteristics and potential muscle origin of microparticles in patients.

Main Methods:

  • Plasma samples from 20 polymyositis/dermatomyositis patients and 20 healthy controls were analyzed using flow cytometry.
  • Monocyte (CD14+), T-lymphocyte (CD3+), and B-lymphocyte (CD19+) derived microparticles were quantified.
  • Electron microscopy was employed to visualize microparticle structure, and creatine kinase (CK) activity was assessed.

Main Results:

  • Significantly higher concentrations of monocyte, T-lymphocyte, and B-lymphocyte derived microparticles were observed in patients compared to controls (p<0.01).
  • Plasma levels of monocyte and B-lymphocyte microparticles correlated with manual muscle strength (p<0.03).
  • Elevated microparticle levels were associated with anti-Jo-1 antibody positivity and lung involvement (p<0.016).

Conclusions:

  • Immune cell-derived microparticles are significantly elevated in polymyositis/dermatomyositis and may contribute to the disease's inflammatory processes.
  • Microparticle levels correlate with disease severity markers, suggesting their potential as biomarkers.
  • Muscle-derived microparticles (CK-positive) do not appear to be a significant component in the blood of these patients.